Editors:
- Examines 5-HT2C receptor subclass as a possible therapeutic target for the development of drugs for a range of CNS disorders such as schizophrenia, depression, drug abuse, eating disorders, Parkinson’s disease and epilepsy
- Updates the functional status of the 5-HT2C receptor
- Written by an international group of accomplished leaders in this field
- Includes supplementary material: sn.pub/extras
Part of the book series: The Receptors (REC, volume 22)
Buy it now
Buying options
Tax calculation will be finalised at checkout
Other ways to access
This is a preview of subscription content, log in via an institution to check for access.
Table of contents (26 chapters)
-
Front Matter
About this book
Reviews
From the reviews:
“The book is well presented with good use of diagrams … . There is a good mix of international authors with acknowledged leaders in the field being responsible for some key chapters. … In summary this is a useful book describing the properties of a receptor that may well turn out to be a therapeutically important drug target with selective ligands already being evaluated in phase II trials for control of appetite.” (R. G. Hill, British Journal of Clinical Pharmacology, May, 2011)Editors and Affiliations
-
, Department of Physiology and Biochemistr, University of Malta, Malta, Italy
Giuseppe Di Giovanni
-
Centro di Ricerche Farmacologiche e, Biomediche, Consorzio Mario Negri Sud, Santa Maria Imbaro, Italy
Ennio Esposito, Vincenzo Di Matteo
Bibliographic Information
Book Title: 5-HT2C Receptors in the Pathophysiology of CNS Disease
Editors: Giuseppe Di Giovanni, Ennio Esposito, Vincenzo Di Matteo
Series Title: The Receptors
DOI: https://doi.org/10.1007/978-1-60761-941-3
Publisher: Humana Totowa, NJ
eBook Packages: Biomedical and Life Sciences, Biomedical and Life Sciences (R0)
Copyright Information: Springer Science+Business Media, LLC 2011
Hardcover ISBN: 978-1-60761-940-6
Softcover ISBN: 978-1-61779-720-0
eBook ISBN: 978-1-60761-941-3
Series ISSN: 1048-6909
Series E-ISSN: 2524-6488
Edition Number: 1
Number of Pages: XII, 560
Topics: Neurosciences, Pharmacology/Toxicology, Human Physiology, Neurobiology, Neurology